FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc (Q24293774)

1

0 references

Cui Long

2

0 references

Du Zhen-dong

3

0 references

Shi Min-min

4

0 references

Wu Wei-ze

5

0 references

Yang Wei-ping

6

0 references

Peng Cheng-hong

Global cancer statistics, 2002

7

0 references

language of work or name

English

0 references

publication date

11 July 2013

0 references

published in

FEBS Letters

0 references

volume

587

0 references

issue

14

0 references

page(s)

2105-11

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Current questions for the treatment of advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

New targeted therapies for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

FOXO transcription factors at the interface between longevity and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

The PKB/FOXO switch in aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

FoxO6 integrates insulin signaling with gluconeogenesis in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

FoxO6 regulates memory consolidation and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

MAX and MYC: a heritable breakup

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Myc: a weapon of mass destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Nuclear receptor coregulators and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Molecular characterization of SMILE as a novel corepressor of nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

MYC on the path to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

HNF-4alpha: from MODY to late-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.05.027